Indications for single-dose activated charcoal administration in acute overdose
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: Gastrointestinal decontamination in overdose patients remains a controversial problem in emergency medicine. There has been a significant decrease in the use of single-dose activated charcoal (SDAC) in recent years based on little new evidence and possibly because the overall mortality in overdose patients is low. RECENT FINDINGS: Human volunteer studies suggest SDAC is effective and this effect occurs for up to 4 h after ingestion, but the magnitude of the reduction in area under the curve (AUC) decreases over time. Two randomized controlled trials including one recent large study did not find SDAC to be beneficial. Pharmacokinetic and pharmacodynamic studies of specific drugs in overdose suggest that for most drugs SDAC decreases drug exposure, but this does not translate to clinical benefit in all cases. The administration of SDAC is a low-risk intervention. SUMMARY: Although SDAC is unlikely to be beneficial in many overdose patients, for some subgroups with severe poisoning, the benefits will outweigh the low risk of administration. The use of SDAC should be based on the potential toxicity of the drug ingested and the potential benefit of SDAC balanced against the willingness of the patient to take SDAC and the low risk of administration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Learning versus confirming in clinical drug development*
Sheiner, L. B. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90160-0 · Cited by 633
Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial
Eddleston, M., Juszczak, E., Buckley, N. A., Senarathna, L., Mohamed, F., Dissanayake, W., Hittarage, A., Azher, S., Jeganathan, K., Jayamanne, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60270-6 · Cited by 227
Buckley, N. A., Buckley, N., Whyte, I. M., O'Connell, D. L., & Dawson, A. H. (1999) · Journal of Toxicology: Clinical Toxicology · doi:10.1081/clt-100102452 · Cited by 112
Cited by
Activated charcoal for acute overdose: a reappraisal
Juurlink, D. N. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12793 · Cited by 128
Stine, J. G., & Lewis, J. H. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1127756 · Cited by 104
Modified release paracetamol overdose: a prospective observational study (ATOM-3)
Chiew, A. L., Isbister, G. K., Page, C. B., Kirby, K. A., Chan, B. S. H., & Buckley, N. A. (2018) · Clinical Toxicology · doi:10.1080/15563650.2018.1439950 · Cited by 30
“As in the awake and alert patient charcoal is a low risk intervention and further studies are required to determine its efficacy in MR paracetamol ingestion [15,16].”
BackgroundSelf-citation
Metadata
- Authors
- Isbister, G. K., & Kumar, V. V. P.
- Venue
- Current Opinion in Critical Care
- Published
- 2011-08
- Volume
- 17
- Issue
- 4
- Pages
- 351-357
- ISSN
- 1070-5295 (ISSN-L)
- OpenAlex
- W2144924297
- Cited by
- 42
- References
- 3
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Indications for single-dose activated charcoal administration in acute overdose. https://app.cochat.ai/papers/10.1097/mcc.0b013e328348bf59
- The paper
- Isbister, G. K., & Kumar, V. V. P. (2011). Indications for single-dose activated charcoal administration in acute overdose. Current Opinion in Critical Care. https://doi.org/10.1097/mcc.0b013e328348bf59
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.